Literature DB >> 17021712

Relationship between the severity of enthesitis and clinical and laboratory parameters in patients with ankylosing spondylitis.

Taciser Kaya1, Serpil Bal, Rezzan Gunaydin.   

Abstract

In this study, we evaluated the relationship between the severity of enthesitis and outcome of measurement indices, clinical and laboratory parameters in patients with ankylosing spondylitis (AS). Thirty-three patients who fulfilled the modified New York criteria for AS were included in this study. Patients were asked to record the severity of current pain, night pain and morning stiffness on a 10-cm visual analogue scale. Stoke Enthesitis Index (SEI) was used to measure the severity of enthesitis. Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI) and Bath Ankylosing Spondylitis Metrology Index (BASMI) were calculated. SEI was correlated positively only with BASDAI (r = 0.370, P = 0.034). There was no relation between SEI and laboratory parameters (Erythrocyte Sedimentation Rate and C Reactive Protein). Our data suggest that using an enthesitis index such as SEI can be a valuable tool in the evaluation of disease activity in patients with AS. However, evaluation of enthesitis severity is based on information given by patient and should be combined with objective parameters such as spinal measurements when assessing disease activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17021712     DOI: 10.1007/s00296-006-0218-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  22 in total

1.  Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis.

Authors:  A Spoorenberg; D van der Heijde; E de Klerk; M Dougados; K de Vlam; H Mielants; H van der Tempel; S van der Linden
Journal:  J Rheumatol       Date:  1999-04       Impact factor: 4.666

2.  Comparison of statistically derived ASAS improvement criteria for ankylosing spondylitis with clinically relevant improvement according to an expert panel.

Authors:  A van Tubergen; D van der Heijde; J Anderson; R Landewé; M Dougados; J Braun; N Bellamy; G Udrea; Sj van der Linden
Journal:  Ann Rheum Dis       Date:  2003-03       Impact factor: 19.103

Review 3.  The anatomical basis for disease localisation in seronegative spondyloarthropathy at entheses and related sites.

Authors:  M Benjamin; D McGonagle
Journal:  J Anat       Date:  2001-11       Impact factor: 2.610

4.  Assessment of peripheral enthesitis in the spondylarthropathies by ultrasonography combined with power Doppler: a cross-sectional study.

Authors:  Maria-Antonietta D'Agostino; Roula Said-Nahal; Cécile Hacquard-Bouder; Jean-Louis Brasseur; Maxime Dougados; Maxime Breban
Journal:  Arthritis Rheum       Date:  2003-02

5.  Ultrasonography of entheseal insertions in the lower limb in spondyloarthropathy.

Authors:  P V Balint; D Kane; H Wilson; I B McInnes; R D Sturrock
Journal:  Ann Rheum Dis       Date:  2002-10       Impact factor: 19.103

6.  The Turkish versions of the Bath Ankylosing Spondylitis and Dougados Functional Indices: reliability and validity.

Authors:  Altinay Goksel Karatepe; Yesim Akkoc; Servet Akar; Yesim Kirazli; Nurullah Akkoc
Journal:  Rheumatol Int       Date:  2004-07-10       Impact factor: 2.631

7.  A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index.

Authors:  A Calin; S Garrett; H Whitelock; L G Kennedy; J O'Hea; P Mallorie; T Jenkinson
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

8.  A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity.

Authors:  Yesim Akkoc; Altinay Goksel Karatepe; Servet Akar; Yesim Kirazli; Nurullah Akkoc
Journal:  Rheumatol Int       Date:  2004-01-17       Impact factor: 2.631

9.  The relationship of clinical and laboratory measurements to radiological change in ankylosing spondylitis.

Authors:  H G Taylor; T Wardle; E J Beswick; P T Dawes
Journal:  Br J Rheumatol       Date:  1991-10

10.  Assessment of enthesitis in ankylosing spondylitis.

Authors:  L Heuft-Dorenbosch; A Spoorenberg; A van Tubergen; R Landewé; H van ver Tempel; H Mielants; M Dougados; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2003-02       Impact factor: 19.103

View more
  6 in total

1.  Clinical and ultrasonographic enthesopathy in inflammatory rheumatic diseases : Is MASEI or only calcaneal enthesitis sufficient?

Authors:  Ekrem Süleyman; Kemal Nas; Halil Harman; Nedim Kaban
Journal:  Z Rheumatol       Date:  2018-10       Impact factor: 1.372

2.  Construct validity and sensitivity to change of Belgrade Ultrasound Enthesitis Score in patients with spondyloarthritis: a pilot study.

Authors:  Sanja Milutinovic; Goran Radunovic; Kristina Veljkovic; Maja Zlatanovic; Nemanja Damjanov
Journal:  Rheumatol Int       Date:  2017-12-13       Impact factor: 2.631

3.  A case of ankylosing spondylitis and discussion of the literature.

Authors:  M P Ranjith; R Divya
Journal:  J Clin Diagn Res       Date:  2013-06-01

4.  Functional limitations due to axial and peripheral joint impairments in patients with ankylosing spondylitis: are focused measures more informative?

Authors:  Siddharth Bethi; Abhijit Dasgupta; Michael H Weisman; Thomas J Learch; Lianne S Gensler; John C Davis; John D Reveille; Michael M Ward
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-04       Impact factor: 4.794

5.  The relationship between enthesitis indices and disease activity parameters in patients with ankylosing spondylitis.

Authors:  Filiz Sivas; Bedriye Mermerci Başkan; Esra Erkol Inal; Lale Akbulut Aktekin; Nurdan Barça; Kürşat Ozoran; Hatice Bodur
Journal:  Clin Rheumatol       Date:  2008-10-24       Impact factor: 2.980

Review 6.  Laboratory evaluation in rheumatic diseases.

Authors:  Murat Birtane; Selçuk Yavuz; Nurettin Taştekin
Journal:  World J Methodol       Date:  2017-03-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.